NASDAQ:ODTX Odyssey Therapeutics Q1 2026 Earnings Report $20.20 -0.22 (-1.08%) As of 09:47 AM Eastern ProfileEarnings HistoryForecast Odyssey Therapeutics EPS ResultsActual EPS-$6.77Consensus EPS -$1.31Beat/MissMissed by -$5.46One Year Ago EPSN/AOdyssey Therapeutics Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AOdyssey Therapeutics Announcement DetailsQuarterQ1 2026Date6/17/2026TimeAfter Market ClosesConference Call DateWednesday, June 17, 2026Conference Call Time8:00AM ETConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Odyssey Therapeutics Earnings HeadlinesOdyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation ForumSeptember 16, 2026 | globenewswire.comOdyssey Therapeutics (ODTX) Banks Two More Years As Trials MultiplySeptember 13, 2026 | insidermonkey.comThe last few crashes started exactly like thisEvery major market crash shared one thing in common: most investors felt confident right before it hit. Overextended valuations, currency pressure, and global economic strain are raising familiar warning signs. The Market Crash Survival Guide from Parkview Capital reviews these historical signals and highlights one asset class that has held its value through past economic collapses. If your retirement is tied to stocks, funds, or a 401k, this free guide is worth a look.October 2 at 1:00 AM | Parkview Capital Group (Ad)Odyssey Therapeutics to Participate in Upcoming Investor ConferencesAugust 26, 2026 | globenewswire.comOdyssey Therapeutics Inc.August 18, 2026 | marketwatch.comOdyssey Therapeutics: Q2 Earnings SnapshotAugust 6, 2026 | chron.comSee More Odyssey Therapeutics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Odyssey Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Odyssey Therapeutics and other key companies, straight to your email. Email Address About Odyssey TherapeuticsOdyssey Therapeutics (NASDAQ:ODTX) is a biotechnology company focused on discovering and developing precision medicines for serious diseases, with an emphasis on immunology and oncology. The company uses a combination of human genetics, functional genomics, computational biology, machine learning and medicinal chemistry to identify disease targets and advance potential therapeutic programs. Odyssey’s research and development activities are centered on small-molecule medicines designed to address genetically validated targets and specific disease mechanisms. Its platform is intended to support drug discovery from early target identification through preclinical development, although detailed information about individual product candidates and their development status may change over time. The company was founded in 2021 and is based in the Boston-Cambridge biotechnology hub in Massachusetts. Gary Glick has been identified as a co-founder and chief executive officer. Odyssey primarily operates in the United States and collaborates with investors, researchers and industry partners in developing medicines for patients with immune-mediated and cancer-related diseases.View Odyssey Therapeutics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Micron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the TestBoeing’s Fighter Victory Opens the Door to Decades of Defense RevenueCleared for Takeoff: AAR Corp. Expands Its Aerospace Aftermarket ReachJabil’s Double-Beat and Raise Is a Signal That This Rally Will ContinueMicrosoft's AI Spending Didn't Change—Wall Street's View of It DidL3Harris’ $6 Billion THAAD Win Comes at a Crucial Moment for the Stock Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
